Search

Your search keyword '"Novo Nordisk A/S -- Reports"' showing total 69 results
Start Over Descriptor "Novo Nordisk A/S -- Reports" Topic business, international
69 results on '"Novo Nordisk A/S -- Reports"'

1. Type 1 Diabetes Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers

Subjects
Vertex Pharmaceuticals Inc. -- Reports, Novo Nordisk A/S -- Reports, Business -- Research, Dapagliflozin -- Reports, Diabetes therapy -- Reports, Insulin glargine -- Reports, Type 1 diabetes -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-October 23, 2024-: Type 1 Diabetes Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers (C)1994-2024 M2 COMMUNICATIONS RDATE:22102024 DelveInsight's, 'Type 1 Diabetes Pipeline Insight 2024' report [...]

Published
2024

2. New study: Ozempic significantly reduces risk of kidney disease death

Subjects
Novo Nordisk A/S -- Reports, Medical research -- Health aspects -- Reports, Medicine, Experimental -- Health aspects -- Reports, Diabetes therapy -- Reports -- Health aspects, Chronic kidney failure -- Risk factors, Hypoglycemic agents -- Reports -- Health aspects, Type 2 diabetes -- Risk factors, Pharmaceutical industry -- Reports -- Health aspects, Business, international, Ozempic (Medication) -- Health aspects -- Reports
Abstract

ALBAWABA Exciting news emerges in the realm of diabetes treatment as groundbreaking research reveals the profound impact of Novo Nordisk's diabetes drug, Ozempic, on patients with Type 2 diabetes and [...]

Published
2024

3. Type 1 Diabetes Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)

Subjects
Vertex Pharmaceuticals Inc. -- Reports, Novo Nordisk A/S -- Reports, Business -- Research, Dapagliflozin -- Reports, Diabetes therapy -- Reports, Insulin glargine -- Reports, Type 1 diabetes -- Reports, Drug approval -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-May 14, 2024-: Type 1 Diabetes Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated) (C)1994-2024 M2 COMMUNICATIONS RDATE:13052024 DelveInsight's, 'Type 1 Diabetes Pipeline [...]

Published
2024

4. Hemophilia A Pipeline Assessment 2024: FDA Approvals, Drugs, Therapies and Companies by DelveInsight | Spark Therapeutics, Sigilon Therapeutics, ASC Therapeutics, Pfizer, Sanofi Genzyme, Novo Nordisk

Subjects
Genzyme Corp. -- Reports, Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Sanofi S.A. -- Reports, Business -- Research, Biotechnology industry -- Reports, Drugs -- Reports, Hemophilia -- Reports, Drug approval -- Reports, Blood coagulation factor VIII -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-March 1, 2024-: Hemophilia A Pipeline Assessment 2024: FDA Approvals, Drugs, Therapies and Companies by DelveInsight | Spark Therapeutics, Sigilon Therapeutics, ASC Therapeutics, Pfizer, Sanofi Genzyme, Novo Nordisk, (C)1994-2024 [...]

Published
2024

5. Novo Nordisk creates a boom in four municipalities

Subjects
Novo Nordisk A/S -- Reports, Pharmaceutical industry -- Reports, Business, international
Abstract

Copenhagen, Denmark: According to a press release, the pharmaceutical industry has been bankrolling the Danish economy in recent years. Now, places like Kalundborg are thriving, with more and more internationals [...]

Published
2024

6. Chronic Kidney Disease Competitive Landscape Report 2023 (Updated) | Boehringer Ingelheim, Eli Lilly, Reata Pharma, Novo Nordisk, KBP Biosciences, AstraZeneca, Allena Pharma, and others

Subjects
Boehringer Ingelheim GmbH -- Reports, AstraZeneca PLC -- Reports, Novo Nordisk A/S -- Reports, Eli Lilly and Co. -- Reports, Business -- Research, Dapagliflozin -- Reports, Chronic kidney failure -- Reports, Erythropoietin, Recombinant -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-December 19, 2023-: Chronic Kidney Disease Competitive Landscape Report 2023 (Updated) | Boehringer Ingelheim, Eli Lilly, Reata Pharma, Novo Nordisk, KBP Biosciences, AstraZeneca, Allena Pharma, and others. (C)1994-2023 M2 [...]

Published
2023

7. Economists Warn Of Costs If US Medicare Covers New Obesity Drugs

Subjects
Novo Nordisk A/S -- Reports, Eli Lilly and Co. -- Reports, Obesity -- Economic aspects -- Reports, Diabetes therapy -- Economic aspects -- Reports, Medicare -- Economic aspects -- Reports, Medical economics -- Economic aspects -- Reports, Drugs -- Prescribing, Hypoglycemic agents -- Economic aspects -- Reports, Economists -- Reports -- Economic aspects, Weight loss -- Reports -- Economic aspects, Pharmaceutical industry -- Reports -- Economic aspects, Business, international, News, opinion and commentary, Wegovy (Medication) -- Reports
Abstract

The cost of expanding U.S. Medicare prescription drug coverage to pay for expensive, new obesity medications could be catastrophic, health economists warned in a report published on Saturday. Big-selling diabetes [...]

Published
2023

8. Economists Warn Of Costs If US Medicare Covers New Obesity Drugs

Subjects
Novo Nordisk A/S -- Reports, Eli Lilly and Co. -- Reports, Obesity -- Economic aspects -- Reports, Diabetes therapy -- Economic aspects -- Reports, Medicare -- Economic aspects -- Reports, Medical economics -- Economic aspects -- Reports, Drugs -- Prescribing, Hypoglycemic agents -- Economic aspects -- Reports, Economists -- Reports -- Economic aspects, Weight loss -- Reports -- Economic aspects, Pharmaceutical industry -- Reports -- Economic aspects, Business, international, News, opinion and commentary, Wegovy (Medication) -- Reports
Abstract

The cost of expanding U.S. Medicare prescription drug coverage to pay for expensive, new obesity medications could be catastrophic, health economists warned in a report published on Saturday. Big-selling diabetes [...]

Published
2023

9. Economists Warn Of Costs If US Medicare Covers New Obesity Drugs

Subjects
Novo Nordisk A/S -- Reports, Eli Lilly and Co. -- Reports, Obesity -- Economic aspects -- Reports, Diabetes therapy -- Economic aspects -- Reports, Medicare -- Economic aspects -- Reports, Medical economics -- Economic aspects -- Reports, Drugs -- Prescribing, Hypoglycemic agents -- Economic aspects -- Reports, Economists -- Reports -- Economic aspects, Weight loss -- Reports -- Economic aspects, Pharmaceutical industry -- Reports -- Economic aspects, Business, international, News, opinion and commentary, Wegovy (Medication) -- Reports
Abstract

The cost of expanding U.S. Medicare prescription drug coverage to pay for expensive, new obesity medications could be catastrophic, health economists warned in a report published on Saturday. Big-selling diabetes [...]

Published
2023

10. Monoclonal Antibodies: Competitive Landscape Report, 2023 Featuring Insights of Novartis, Gmax Biopharm, Omeros Corp, and Merck Sharp & Dohme Among ~180 Other Players

Subjects
Merck KGaA -- Reports, Bristol-Myers Squibb Co. -- Reports, Novartis AG -- Reports, AstraZeneca PLC -- Reports, Novo Nordisk A/S -- Reports, Biological products -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-June 7, 2023-: Monoclonal Antibodies: Competitive Landscape Report, 2023 Featuring Insights of Novartis, Gmax Biopharm, Omeros Corp, and Merck Sharp & Dohme Among ~180 Other Players (C)1994-2023 M2 COMMUNICATIONS [...]

Published
2023

11. European Energy A|S expresses confidence for another solid year with their Q1 report

Subjects
Novo Nordisk A/S -- Reports, Alternative energy sources -- Reports, Energy industry -- Reports, Pharmaceutical industry -- Reports, Business, international
Abstract

Copenhagen: European Energy A/S has issued the following news release: In the first quarter of 2023 several milestones have been achieved by European Energy, as the company passed 1 GW [...]

Published
2023

12. Acquired Hemophilia A Pipeline constitutes 10+ key companies continuously working towards developing 10+ Acquired Hemophilia A treatment therapies, Analyzes DelveInsight

Subjects
Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Business -- Research, Blood coagulation factors -- Reports, Hemophilia -- Reports, Blood coagulation factor VIII -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-April 27, 2023-: Acquired Hemophilia A Pipeline constitutes 10+ key companies continuously working towards developing 10+ Acquired Hemophilia A treatment therapies, Analyzes DelveInsight (C)1994-2023 M2 COMMUNICATIONS RDATE:26042023 (New York, [...]

Published
2023

13. United States : Statement from President Joe Biden on February CPI Report

Subjects
Novo Nordisk A/S -- Reports, Pharmaceutical industry -- Reports, Business, international
Abstract

Report shows annual inflation is down by a third from this summer at a time when the unemployment rate remains near a 50-year low. That is the slowest annual increase [...]

Published
2023

14. Hemophilia Pipeline Analysis: 80+ Companies are Working to Improve the Treatment Space | DelveInsight

Subjects
Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Sanofi S.A. -- Reports, Business -- Research, Hemophilia -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-November 8, 2022-: Hemophilia Pipeline Analysis: 80+ Companies are Working to Improve the Treatment Space | DelveInsight (C)1994-2022 M2 COMMUNICATIONS RDATE:07112022 DelveInsight's, 'Hemophilia Pipeline Insight, 2022,' report provides comprehensive [...]

Published
2022

15. Human Growth Hormone Market Is Boosting Up Economy With 8.2% CAGR, Owing To Rising Awareness For Diagnosis And Treatment of Growth Hormone Disorders Till 2027 | Grand View Research, Inc

Subjects
Novo Nordisk A/S -- Reports, Medical research -- Economic aspects -- Reports, Medicine, Experimental -- Economic aspects -- Reports, Somatotropin -- Market size -- Reports -- Economic aspects, Pharmaceutical industry -- Reports -- Market size -- Economic aspects, Business, Business, international
Abstract

M2 PRESSWIRE-May 4, 2022-: Human Growth Hormone Market Is Boosting Up Economy With 8.2% CAGR, Owing To Rising Awareness For Diagnosis And Treatment of Growth Hormone Disorders Till 2027 | [...]

Published
2022

16. Global Insulin Pens Market Outlook & Forecast Report 2022-2027 Featuring Leading Vendors - Lilly, Medtronic, Novo Nordisk, and Sanofi - ResearchAndMarkets.com

Subjects
Novo Nordisk A/S -- Reports, Sanofi S.A. -- Reports, Insulin -- Reports, Pharmaceutical industry -- Industry forecasts, Business, Business, international
Abstract

DUBLIN -- The 'Insulin Pens Market - Global Outlook & Forecast 2022-2027' report has been added to ResearchAndMarkets.com's offering. The insulin pens market is expected to grow at a CAGR [...]

Published
2022

17. Global Insulin Pens Market Outlook & Forecast Report 2022-2027 Featuring Leading Vendors - Lilly, Medtronic, Novo Nordisk, and Sanofi

Subjects
Novo Nordisk A/S -- Reports, Sanofi S.A. -- Reports, Insulin -- Reports, Pharmaceutical industry -- Industry forecasts, Business, Business, international
Abstract

M2 PRESSWIRE-April 7, 2022-: Global Insulin Pens Market Outlook & Forecast Report 2022-2027 Featuring Leading Vendors - Lilly, Medtronic, Novo Nordisk, and Sanofi (C)1994-2022 M2 COMMUNICATIONS RDATE:07042022 The 'Insulin Pens [...]

Published
2022

18. Outlook on the Protein Therapeutics Global Market to 2026 - by Product, Therapy Area, Function and Region - ResearchAndMarkets.com

Subjects
Merck & Company Inc. -- Reports, Biogen Inc. -- Reports, Amgen Inc. -- Reports, Hoffmann-La Roche AG -- Reports, Baxter International Inc. (Deerfield, Illinois) -- Reports, Johnson & Johnson -- Reports, AbbVie Inc. -- Reports, CSL Ltd. (Parkville, Victoria, Australia) -- Reports, Eli Lilly and Co. -- Reports, Novo Nordisk A/S -- Reports, Abbott Laboratories (Abbott Park, Illinois) -- Reports, Roche Holding AG -- Reports, Biological products industry -- Industry forecasts, Medical test kit industry -- Industry forecasts, Biotechnology industry -- Industry forecasts, Medical equipment and supplies industry -- Industry forecasts, Pharmaceutical industry -- Industry forecasts, Business, Business, international
Abstract

DUBLIN -- The 'Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026' report has been added to ResearchAndMarkets.com's offering. The global protein therapeutics market exhibited moderate [...]

Published
2021

19. Outlook on the Protein Therapeutics Global Market to 2026 - by Product, Therapy Area, Function and Region

Subjects
Merck & Company Inc. -- Reports, Biogen Inc. -- Reports, Amgen Inc. -- Reports, Baxter International Inc. (Deerfield, Illinois) -- Reports, AbbVie Inc. -- Reports, Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Eli Lilly and Co. -- Reports, Abbott Laboratories (Abbott Park, Illinois) -- Reports, Hoffmann-La Roche AG -- Reports, Johnson & Johnson -- Reports, CSL Ltd. (Parkville, Victoria, Australia) -- Reports, Roche Holding AG -- Reports, Biological products industry -- Industry forecasts, Medical test kit industry -- Industry forecasts, Biotechnology industry -- Industry forecasts, Medical equipment and supplies industry -- Industry forecasts, Pharmaceutical industry -- Industry forecasts, Business, Business, international
Abstract

M2 PRESSWIRE-October 18, 2021-: Outlook on the Protein Therapeutics Global Market to 2026 - by Product, Therapy Area, Function and Region (C)1994-2021 M2 COMMUNICATIONS RDATE:18102021 The 'Protein Therapeutics Market: Global [...]

Published
2021

20. Nonalcoholic Steatohepatitis Pipeline Insight Report 2021 - ResearchAndMarkets.com

Subjects
Novo Nordisk A/S -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

DUBLIN -- The 'Nonalcoholic Steatohepatitis - Pipeline Insight, 2021' drug pipelines has been added to ResearchAndMarkets.com's offering. This 'Nonalcoholic Steatohepatitis - Pipeline Insight, 2021,' report provides comprehensive insights about 140+ [...]

Published
2021

21. Diabetes Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Daewoong Tradipitant, Janssen Biotech, Zealand Pharma, Provention Bio, ImCyse, Novo Nordisk, Enthera, ActoBio Th

Subjects
Novo Nordisk A/S -- Reports, Business -- Research, Diabetes therapy -- Reports, Biotechnology -- Reports, Type 2 diabetes -- Care and treatment, Pharmaceutical industry -- Reports, Insulin lispro -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-April 15, 2021-: Diabetes Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Daewoong Tradipitant, Janssen Biotech, Zealand Pharma, Provention Bio, ImCyse, Novo Nordisk, Enthera, ActoBio Th [...]

Published
2021

22. Sickle Cell Disease Pipeline Analysis, unmet needs, opportunities, Key Players: Sanofi, Pfizer, Bristol Myers Squibb, Gilead Sciences, Novo Nordisk and Many More

Subjects
Gilead Sciences Inc. -- Reports, Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Sanofi S.A. -- Reports, Biological products industry -- Reports, Sickle cell anemia -- Diagnosis, Business -- Research, Medical research -- Reports, Medicine, Experimental -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-March 9, 2021-: Sickle Cell Disease Pipeline Analysis, unmet needs, opportunities, Key Players: Sanofi, Pfizer, Bristol Myers Squibb, Gilead Sciences, Novo Nordisk and Many More (C)1994-2021 M2 COMMUNICATIONS RDATE:09032021 [...]

Published
2021

23. NF-kappa B Inhibitors Therapeutics Pipeline Analysis of 80+ Companies

Subjects
Merck & Company Inc. -- Reports, Novo Nordisk A/S -- Reports, Business research -- Reports, Pharmaceutical industry -- Reports, Business, international, Law
Abstract

(GlobeNewswire) - NF-kappa B Inhibitors Therapeutics Pipeline Analysis of 80+ Companies The Key Players involved in developing the NF-kappa B Inhibitors therapies are AnGes MG, Complexa, Accendatech, Serenex, OncoViRx, Novo [...]

Published
2020

24. United Kingdom : Wavemaker named 2020s most successful agency so far

Subjects
Burger King Corp. -- Reports, Novo Nordisk A/S -- Reports, Restaurant industry -- Reports, Pharmaceutical industry -- Reports, Business, international
Abstract

Wavemaker is the worlds best performing media agency according to COMvergences New Business Barometer (Q1-Q3 2020). In the just released report from the independent research company, Wavemaker leads the agency [...]

Published
2020

25. The Global Smart Insulin Pen Market is expected to grow from USD 23.09 Million in 2018 to USD 63.89 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 15.64%

Subjects
Hoffmann-La Roche AG -- Reports, Eli Lilly and Co. -- Reports, Novo Nordisk A/S -- Reports, Insulet Corp. -- Reports, Medical equipment industry -- Reports, Medical informatics -- Reports, Pharmaceutical industry -- Reports, Insulin -- Reports, Biological products industry -- Reports, Technology, Medical equipment, Legal fees, Vendor relations, Business, international, Law
Abstract

(GlobeNewswire) - Reportlinker.com announces the release of the report 'Global Smart Insulin Pen Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025' [...]

Published
2020

26. Global Biologics Market: Insight, Competition and Forecast (2020-2025) Featuring Eli Lilly, Sanofi, Pfizer, Roche, AbbVie, Amgen, Merck & Co, Novo Nordisk, BMS, and Johnson & Johnson - ResearchAndMarkets.com

Subjects
Johnson & Johnson -- Reports, Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Eli Lilly and Co. -- Reports, Chronic diseases -- Reports, Pharmaceutical industry -- Industry forecasts -- Reports, Medical economics, End users, Diseases, Business, Business, international
Abstract

DUBLIN -- The 'Global Biologics Market: Analysis By Product Type, Application Type, Product Pipeline, End User, By Region, By Country (2020 Edition): Market Insight, Competition and Forecast (2020-2025)' report has [...]

Published
2020

27. New drugs drive Novo Nordisk despite insulin price pressures

Subjects
Novo Nordisk A/S -- Reports, Diabetes therapy -- Reports, Pharmaceutical industry -- International economic relations -- Reports, Insulin detemir -- Reports, Semaglutide -- Reports, Pricing, Business, international, Law
Abstract

Novo Nordisk has revealed its fourth quarter report, posting a surprise increase in sales for the quarter but forecasted pricing pressure on its insulin products could hurt overall growth this [...]

Published
2020

28. Gilead and Novo Nordisk Report Expanded NASH Clinical Collaboration

Subjects
Gilead Sciences Inc. -- Reports, Novo Nordisk A/S -- Reports, Biological products industry -- Reports, Drug therapy, Combination -- Reports, Liver -- Reports, Liver diseases -- Reports, Pharmaceutical industry -- Reports, Business, Business, international, Telecommunications industry
Abstract

Gilead Sciences and Novo Nordisk reported that the companies have expanded their clinical collaboration in non-alcoholic steatohepatitis (NASH). According to a media release, the companies will conduct a Phase 2b [...]

Published
2021

29. Obesity Market Spotlight 2019: 10-year Disease Prevalence Forecast, Licensing and Acquisition Deals, Drug-specific Revenue Forecasts

Subjects
AstraZeneca PLC -- Reports, Novo Nordisk A/S -- Reports, Obesity -- Reports, Pharmaceutical industry -- Reports, Business, Business, international, Belviq (Medication) -- Reports
Abstract

M2 PRESSWIRE-December 3, 2019-: Obesity Market Spotlight 2019: 10-year Disease Prevalence Forecast, Licensing and Acquisition Deals, Drug-specific Revenue Forecasts (C)1994-2019 M2 COMMUNICATIONS RDATE:03122019 The 'Market Spotlight: Obesity' report has been [...]

Published
2019

30. Obesity Market Spotlight 2019: 10-year Disease Prevalence Forecast, Licensing and Acquisition Deals, Drug-specific Revenue Forecasts - ResearchAndMarkets.com

Subjects
AstraZeneca PLC -- Reports, Novo Nordisk A/S -- Reports, Obesity -- Reports, Pharmaceutical industry -- Reports, Business, Business, international, Belviq (Medication) -- Reports
Abstract

DUBLIN -- The 'Market Spotlight: Obesity' report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Obesity market, comprising key marketed and pipeline drugs, clinical trials, recent [...]

Published
2019

31. Clinical Trials Market Advance & Cost Effective Technology 2019 to 2023 - By Industry Size, Share, Company Profiles, Impressive Growth, Demand, Latest Research & Future Profit

Subjects
Pfizer Inc. -- Reports, Charles River Laboratories Corp. -- Reports, Laboratory Corporation of America Holdings -- Reports, Eli Lilly and Co. -- Reports, ICON PLC -- Reports, Novo Nordisk A/S -- Reports, Health care industry -- International economic relations -- Reports, Medical research -- Reports, Agricultural industry -- International economic relations -- Reports, Pharmaceutical industry -- International economic relations -- Reports, Technology, End users, Hospitals, Health care industry, Business, Business, international
Abstract

M2 PRESSWIRE-November 4, 2019-: Clinical Trials Market Advance & Cost Effective Technology 2019 to 2023 - By Industry Size, Share, Company Profiles, Impressive Growth, Demand, Latest Research & Future Profit [...]

Published
2019

32. Corporate Reputation of Pharma in 2018 from Bleeding Disorders Patients: The Views of 27 Patient Groups of Bayer, CSL Behring, Grifols, Novo Nordisk, Octapharma, Pfizer, Roche, Takeda/Shire

Subjects
Bayer AG -- Reports, Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Hemophilia -- Reports -- Surveys, Pharmaceutical industry -- Reports -- Surveys, Hematologic diseases -- Reports -- Surveys, Business, Business, international
Abstract

M2 PRESSWIRE-September 19, 2019-: Corporate Reputation of Pharma in 2018 from Bleeding Disorders Patients: The Views of 27 Patient Groups of Bayer, CSL Behring, Grifols, Novo Nordisk, Octapharma, Pfizer, Roche, [...]

Published
2019

33. Global Diabetes Market 2019 - Industry Analysis, Size, Share, Key Players, Applications, Strategies and Forecast to 2023

Subjects
Merck & Company Inc. -- Reports, Novartis AG -- Reports, Novo Nordisk A/S -- Reports, Sanofi S.A. -- Reports, Pharmaceutical industry -- Industry forecasts -- Reports, Technology, Business, Business, international
Abstract

M2 PRESSWIRE-September 4, 2019-: Global Diabetes Market 2019 - Industry Analysis, Size, Share, Key Players, Applications, Strategies and Forecast to 2023 (C)1994-2019 M2 COMMUNICATIONS RDATE:04092019 Wise Guy Reports Published Latest [...]

Published
2019

34. 2019 Anti-Obesity Drugs Report: Global Market Analysis, Trends and Forecasts Through 2015-2024 - ResearchAndMarkets.com

Subjects
F. Hoffmann-La Roche Ltd. -- Reports, VIVUS Inc. -- Reports, Novo Nordisk A/S -- Reports, GlaxoSmithKline PLC -- Reports, Eisai Company Ltd. -- Reports, Obesity -- Reports, Drugs -- Reports, Biotechnology industries -- Industry forecasts -- Reports, Pharmaceutical industry -- Industry forecasts -- Reports, Semaglutide -- Reports, Lorcaserin -- Reports, Anti-obesity agents, Business, Business, international, Contrave (Medication) -- Reports, Belviq (Medication) -- Reports
Abstract

DUBLIN -- The 'Anti-Obesity Drugs: Global Market Analysis, Trends, and Forecasts' report has been added to ResearchAndMarkets.com's offering. This report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, [...]

Published
2019

35. 2019 Anti-Obesity Drugs Report: Global Market Analysis, Trends and Forecasts Through 2015-2024

Subjects
F. Hoffmann-La Roche Ltd. -- Reports, VIVUS Inc. -- Reports, Novo Nordisk A/S -- Reports, GlaxoSmithKline PLC -- Reports, Eisai Company Ltd. -- Reports, Obesity -- Reports, Drugs -- Reports, Biotechnology industries -- Industry forecasts -- Reports, Pharmaceutical industry -- Industry forecasts -- Reports, Lorcaserin -- Reports, Semaglutide -- Reports, Anti-obesity agents, Business, Business, international, Contrave (Medication) -- Reports, Belviq (Medication) -- Reports
Abstract

M2 PRESSWIRE-June 12, 2019-: 2019 Anti-Obesity Drugs Report: Global Market Analysis, Trends and Forecasts Through 2015-2024 (C)1994-2019 M2 COMMUNICATIONS RDATE:12062019 The 'Anti-Obesity Drugs: Global Market Analysis, Trends, and Forecasts' report [...]

Published
2019

36. Contraceptives Drugs Market 2019 Global Industry Trends, Sales, Supply, Consumption, Demand, Analysis and Forecasts to 2025

Subjects
Bayer Company Inc. -- Reports, Novo Nordisk A/S -- Reports, HVAC industry -- Industry forecasts -- Reports, Pharmaceutical industry -- Industry forecasts -- Reports, Business, Business, international
Abstract

Wiseguyreports.Com adds 'Contraceptives Drugs Market -Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025' To Its Research Database. Contraceptives Drugs Market 2019Wiseguyreports.Com adds 'Contraceptives Drugs Market [...]

Published
2019

37. Human Growth Hormone Markets: Worldwide Outlook (2018-2022) with Eli Lilly, F. Hoffmann-La Roche, Novo Nordisk and Pfizer Leading - ResearchAndMarkets.com

Subjects
Merck & Company Inc. -- Reports, Eli Lilly and Co. -- Reports, Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Pharmaceutical industry -- Industry forecasts -- Reports, Business, Business, international
Abstract

DUBLIN -- The 'Global Human Growth Hormone Market 2018-2022' report has been added to ResearchAndMarkets.com's offering.The human growth hormone market will register a CAGR of almost 4% by 2022.Increasing incidence [...]

Published
2019

39. Investigation Report on China's Insulin Detemir Market, 2018-2022

Subjects
Novo Nordisk A/S -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

The 'Investigation Report on China's Insulin Detemir Market, 2018-2022' report has been added to ResearchAndMarkets.com's offering.In the past three decades, the incidence of diabetes kept rising in China with the [...]

Published
2019

40. Insulin Delivery Devices Market by Syringe, Pumps, Pens, Jet Injectors and Forecasts Till 2020

Subjects
Becton, Dickinson and Co. -- Reports, Medtronic PLC -- Reports, Animas Corp. -- Reports, Novo Nordisk A/S -- Reports, Eli Lilly and Co. -- Reports, Sanofi S.A. -- Reports, Insulet Corp. -- Reports, Diabetes therapy -- Reports, Medical test kit industry -- Reports, Medical equipment and supplies industry -- Reports, Insulin -- Reports, Medical supplies -- Reports, Type 2 diabetes -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-September 18, 2017-: Insulin Delivery Devices Market by Syringe, Pumps, Pens, Jet Injectors and Forecasts Till 2020 (C)1994-2017 M2 COMMUNICATIONS RDATE:18092017 The Global Insulin Delivery Devices Market report explores [...]

Published
2017

41. Global Diabetes Pen Market Organization Size, Top Manufacturers, Service Providers, Solutions Forecast to 2021

Subjects
Merck & Company Inc. -- Reports, Novo Nordisk A/S -- Reports, Eli Lilly and Co. -- Reports, Sanofi S.A. -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-January 23, 2017-: Global Diabetes Pen Market Organization Size, Top Manufacturers, Service Providers, Solutions Forecast to 2021 (C)1994-2017 M2 COMMUNICATIONS RDATE:23012017 Market Highlights: The Diabetes Pen Market has experienced [...]

Published
2017

42. Pharmaceuticals Manufacturers (Global) - Industry Report 2016: Individual Analysis of the Top 90 Companies Including Pfizer Inc, Novo Nordisk A/S & Allergan Inc - Research and Markets

Subjects
Allergan Inc. (Irvine, California) -- Reports, Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

DUBLIN -- Research and Markets has announced the addition of the 'Pharmaceuticals Manufacturers (Global) - Industry Report' report to their offering. The Pharmaceuticals Manufacturers (Global) Analysis provides a detailed overview [...]

Published
2016

43. Pharmaceuticals Manufacturers (Global) - Industry Report 2016: Individual Analysis of the Top 90 Companies Including Pfizer Inc, Novo Nordisk A/S & Allergan Inc

Subjects
Allergan Inc. (Irvine, California) -- Reports, Pfizer Inc. -- Reports, Novo Nordisk A/S -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-September 23, 2016-: Pharmaceuticals Manufacturers (Global) - Industry Report 2016: Individual Analysis of the Top 90 Companies Including Pfizer Inc, Novo Nordisk A/S & Allergan Inc (C)1994-2016 M2 COMMUNICATIONS [...]

Published
2016

44. New Forecast Report - Latin America Insulin Market Size 2020: Radiant Insights, Inc

Subjects
Novo Nordisk A/S -- Reports, Sanofi S.A. -- Reports, Pharmaceutical industry -- Industry forecasts -- Reports, Insulin -- Reports, Business, Business, international
Abstract

M2 PRESSWIRE-January 20, 2016-Radiant Insights: New Forecast Report - Latin America Insulin Market Size 2020: Radiant Insights, Inc (C)1994-2016 M2 COMMUNICATIONS RDATE:20012016 The Latin America market for Insulin is expected [...]

Published
2016

45. Insulin Market in Europe - Technavio Analyses Trends & Forecast

Subjects
Eli Lilly and Co. -- Reports, Novo Nordisk A/S -- Reports, Sanofi S.A. -- Reports, Pharmaceutical industry -- Industry forecasts -- Reports, Insulin -- Reports, Business, Business, international
Abstract

Eli Lilly and Co., Novo Nordisk A/S, and Sanofi SA are three key vendors highlighted in a new Technavio report LONDON -- Technavio has published a new report on the [...]

Published
2015

46. Lupin receives USFDA approval for anti-diabetes drug: Report; The product is expected to have sales of $200-$300 million in the US

Subjects
Novo Nordisk A/S -- Reports, Diabetes mellitus -- Reports, Hypoglycemic agents -- Reports, Pharmaceutical industry -- Reports, Business, international
Abstract

The product is expected to have sales of $200-$300 million in the US Pharma Major Lupin, has reportedly received an approval from the USFDA for PrandiMet (also known as Prandin) [...]

Published
2015

47. NNIT A/S: 15/2015 Financial report for Q1 2015

Subjects
Thomson Reuters Corp. -- Reports, Novo Nordisk A/S -- Reports, Information services -- Reports, Pharmaceutical industry -- Reports, Information services industry, Business, international
Abstract

(Thomson Reuters ONE via COMTEX) -- Organic revenue growth of 10.4% and an operating profit margin of 11.6% in constant currencies Performance highlights - Revenue increased by 10.4% in constant [...]

Published
2015

48. Research and Markets: China Insulin Industry Report, 2012-2015

Subjects
Eli Lilly and Co. -- Reports, Novo Nordisk A/S -- Reports, Insulin -- Reports, Pharmaceutical industry -- Reports, Business, Business, international
Abstract

DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/fn898w/china_insulin) has announced the addition of the 'China Insulin Industry Report, 2012-2015' report to their offering. Due to high technological content and entry barriers, Chinese [...]

Published
2013

49. Interim financial report for the period 1 January 2010 to 30 September 2010

Subjects
Novo Nordisk A/S -- Reports, Pharmaceutical industry -- Reports, Business, Business, international, News, opinion and commentary
Abstract

Byline: BAGSVAERD, DENMARK, Oct 27, 2010 (MARKETWIRE via COMTEX) -- Novo Nordisk's operating profit up by 24% in the first nine months of 2010 Sales grew by 17% driven by [...]

Published
2010

50. Novo Nordisk A/S: Interim financial report for the period 1 January 2010 to 30 June 2010

Subjects
Novo Nordisk A/S -- Reports, Pharmaceutical industry -- Reports, Business, Business, international, News, opinion and commentary
Abstract

Byline: BAGSVAERD, DENMARK, Aug 05, 2010 (MARKETWIRE via COMTEX) -- Novo Nordisk increased operating profit by 19% in the first half of 2010 Sales growth of 14% driven by modern [...]

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results